Corporate Team
Dr. Sanjay B. Wagh
Proprietor
Dr. Sanjay Wagh has over 40 years of experience in designing innovative synthetic routes for organic molecules. He has synthesized nearly 5000 molecules for drug discovery programs and holds multiple patents along with 25+ peer-reviewed publications.
With 18+ years in business development, he brings deep insights into APIs, intermediates, specialty chemicals, and key starting materials. He has successfully commercialized 30+ molecules across multiple domains.
His expertise includes Catalytic Hydrogenation, Nitration, Friedel-Crafts reactions, anthraquinone chemistry, and heterocyclic chemistry, with a strong focus on sustainable technologies.
List of Patents - Sanjay Wagh
| No. | Application No. & Date | Applicants | Title of Invention | Status | Patent No. |
|---|---|---|---|---|---|
| 1 |
202121050383 DOF: 02/11/2021 |
1. Wagh Sanjay Baburao 2. Mrunmai Radhesham Tapadia |
"A PROCESS FOR SYNTHESIS OF N-ETHYL METHYL AMINE AND THE DERIVATIVES THEREOF" | Granted | 398580 |
| 2 |
202521022508, PCT DOF: 12/03/2025 |
1. Mrunmai Radhesham Tapadia 2. Hitesh H Patel |
"A Process for Preparing Solid Sucrose Acetate Isobutyrate formulation" | Granted | 577342 |
| 3 | PCT/IN2026/050187 |
1. Mrunmai Radhesham Tapadia 2. Hitesh H Patel |
"A Process for Preparing Solid Sucrose Acetate Isobutyrate formulation" | - | - |
| 4 |
202621038307 DOF: 27/03/2026 |
1. Mr. Ajay Jadhav 2. Dongre Santoshkumar Hanmantrao 3. Dr. Sanjay Baburao Wagh 4. Mrunmai Radhesham Tapadia |
"PROCESS FOR THE ISOLATION OF POTASSIUM IN THE FORM OF POTASSIUM SULPHATE FROM SUGARCANE BAGASSE ASH AND/OR DRIED PRESS MUD" | Awaiting Complete Specification | - |
Indian Patents
-
Patent Application No. 30/MUM/13 (04/01/2013)
Title: Synthesis of silver salt of various sulphonamides and fatty acids for Burn Care
Authority: Government of India, Patent Office, Mumbai -
Patent Application No. 31/MUM/13 (04/01/2013)
Title: Synthesis and characterization of Novel Di-azo crosslinked polymer for colon specific Delivery (Oncology Application) -
Patent No. 398580 (Granted: 06/06/2022)
Authors: S. B. Wagh
Title: A Process of Synthesis of N-Ethylmethyl Amine and the derivatives Thereof
Professional Experience
Proprietorship (2013 – 2022)
- Last 10 Years with Fine Chemical and API Manufacturer at Director Level.
- Visited China several times for Business Development and Technology Transfer.
- Experience of Business development in Japan for 15 Years.
- Consultant to “Fine Corporation, Japan” for last 8 years.
- Established an API manufacturing facility (75 kl capacity) right from EC-CTE-CTO level
- Licenses: Environmental Clearance (EC), CTE (Pollution control Board), CTO(PCB), Marine disposal permit, Methanol License etc.
- Plant Erection: Complete erection of a plant of 110KL capacity with GLR, SSR, ANFD, CNF, RCVD, Scrubbers, MEE, ETP, Utilities.
- Business Development: Travelled from 1997-CPhI London, Paris, Amsterdam, Frankfurt, Munich, Tokyo, Shanghai, Philadelphia, Vienna.
- Developed Business in Japan, Europe, USA, and ROW Market.
- Developed bulk API and intermediate technologies which are cost effective, eco-Friendly and high throughput.
- Successfully produced high value solvent dyes and exported to Japan (Price range $90 to $400/kg) in Bulk quantities. (Export last 3 years’ worth INR 1.3 billion to Japan)
- Exported intermediates for electronic applications to Japan with stringent Trace Metal Specs.
- Experience in developing and successfully implementing industrial scale Catalytic Hydrogenation reactions using Nickel & Palladium Catalysts.
- Currently handling API & API Intermediates projects of worth INR 1 billion
Founder – Sampro Organic Research Laboratories (2002 – 2013)
- Contract manufacturing unit established independently
- SORL has exported more than 1000 custom manufactured products in multikilogram scale for last 7 years.
- SORL has exported more than 5000 screening compounds for drug discovery research (only Export, Chem Navigators, now Sigma Aldrich, USA + Astrazeneka).
- SORL has 5 patents to its credit in antifungal and antipsychotic therapeutic category.
- SORL products were widely accepted across the world - USA, JAPAN, RUSSIA, EAST EUROPIAN COUNTRIES. SORL worked with number of chemical research organizations (CRO) in India like GVK Biosciences Pvt. Ltd., Hyderabad, TCG Life sciences Ltd., Pune and number of R & D departments of pharma industries.
